Keyword: Centers for Disease Control and Prevention
A CDC advisory committee again recommended against using AstraZeneca's FluMist for the upcoming flu season.
Shingrix met its goal in a study examining whether it can protect older adults who previously received Merck’s Zostavax.
A new study finds that Merck’s Gardasil may provide additional protection not included in its official FDA label.
The CDC is recommending PaxVax’s Vaxchora, the only FDA-approved cholera vaccine, for adults aged 18 to 64 traveling to areas where cholera is active.
Sanofi Pasteur’s chief quality officer says vaccinemakers need help tackling a lurking challenge: global regulatory entanglements.
The ongoing global yellow fever vaccine shortage has hit the U.S., as Sanofi Pasteur’s YF-VAX, the only FDA-approved prophylactic shot for the disease, will soon run out.
Sanofi’s vaccines business leaned on strong performances from pediatric, flu and travel shots on the way to 13.2% growth in Q1.
Prompts on electronic health records could make a big difference in flu vaccination rates.
Protein Sciences will start the search for two new H7N9 vaccine candidates by request of the HHS’ Biomedical Advanced Research and Development Authority.
Those who counted President Donald Trump an ally against vaccines might be disappointed in his pick to lead the FDA.